BEVERLY HILLS, Calif. (AP) _ Capricor Therapeutics Inc. (CAPR) on Wednesday reported a loss of $2.7 million in its third quarter.
The Beverly Hills, California-based company said it had a loss of 12 cents per share.
The biotechnology company posted revenue of $313,300 in the period. Its adjusted revenue was $313,000.
In the final minutes of trading on Wednesday, the company's shares hit $2.32. A year ago, they were trading at $2.87.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CAPR at https://www.zacks.com/ap/CAPR